PortalPublikationenThe potential of circulating tumor cells as a liquid biopsy ...

The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.

Standard

The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. / Pantel, Klaus; Alix-Panabières, Catherine.

in: CANCER DISCOV, Jahrgang 2, Nr. 11, 11, 2012, S. 974-975.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Pantel, K & Alix-Panabières, C 2012, 'The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.', CANCER DISCOV, Jg. 2, Nr. 11, 11, S. 974-975. <http://www.ncbi.nlm.nih.gov/pubmed/23093252?dopt=Citation>

APA

Pantel, K., & Alix-Panabières, C. (2012). The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. CANCER DISCOV, 2(11), 974-975. [11]. http://www.ncbi.nlm.nih.gov/pubmed/23093252?dopt=Citation

Vancouver

Pantel K, Alix-Panabières C. The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. CANCER DISCOV. 2012;2(11):974-975. 11.

Bibtex

@article{f13303de5525491cabfa814793ec3363,
title = "The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.",
abstract = "Miyamoto and colleagues present data that prostate-specific antigen/prostate-specific membrane antigen (PSA/PSMA)-based measurements of androgen receptor (AR) signaling in circulating tumor cells (CTC) enable real-time quantitative monitoring of intratumoral AR signaling. This finding indicates that measuring AR signaling within CTCs may help to guide therapy in metastatic prostate cancer and highlights the use of CTCs as liquid biopsy.",
keywords = "Humans, Male, Tumor Markers, Biological/*metabolism, Neoplasms, Hormone-Dependent/*metabolism, Neoplastic Cells, Circulating/*metabolism, Prostatic Neoplasms/*metabolism, Receptors, Androgen/*metabolism, Humans, Male, Tumor Markers, Biological/*metabolism, Neoplasms, Hormone-Dependent/*metabolism, Neoplastic Cells, Circulating/*metabolism, Prostatic Neoplasms/*metabolism, Receptors, Androgen/*metabolism",
author = "Klaus Pantel and Catherine Alix-Panabi{\`e}res",
year = "2012",
language = "English",
volume = "2",
pages = "974--975",
journal = "CANCER DISCOV",
issn = "2159-8274",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

RIS

TY - JOUR

T1 - The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.

AU - Pantel, Klaus

AU - Alix-Panabières, Catherine

PY - 2012

Y1 - 2012

N2 - Miyamoto and colleagues present data that prostate-specific antigen/prostate-specific membrane antigen (PSA/PSMA)-based measurements of androgen receptor (AR) signaling in circulating tumor cells (CTC) enable real-time quantitative monitoring of intratumoral AR signaling. This finding indicates that measuring AR signaling within CTCs may help to guide therapy in metastatic prostate cancer and highlights the use of CTCs as liquid biopsy.

AB - Miyamoto and colleagues present data that prostate-specific antigen/prostate-specific membrane antigen (PSA/PSMA)-based measurements of androgen receptor (AR) signaling in circulating tumor cells (CTC) enable real-time quantitative monitoring of intratumoral AR signaling. This finding indicates that measuring AR signaling within CTCs may help to guide therapy in metastatic prostate cancer and highlights the use of CTCs as liquid biopsy.

KW - Humans

KW - Male

KW - Tumor Markers, Biological/metabolism

KW - Neoplasms, Hormone-Dependent/metabolism

KW - Neoplastic Cells, Circulating/metabolism

KW - Prostatic Neoplasms/metabolism

KW - Receptors, Androgen/metabolism

KW - Humans

KW - Male

KW - Tumor Markers, Biological/metabolism

KW - Neoplasms, Hormone-Dependent/metabolism

KW - Neoplastic Cells, Circulating/metabolism

KW - Prostatic Neoplasms/metabolism

KW - Receptors, Androgen/metabolism

M3 - SCORING: Journal article

VL - 2

SP - 974

EP - 975

JO - CANCER DISCOV

JF - CANCER DISCOV

SN - 2159-8274

IS - 11

M1 - 11

ER -